Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Generally healthy, postmenopausal women who seek treatment for hot flushes~* Body Mass Index (BMI) less than or equal to 34 kg/m\^2~Exclusion Criteria:~* Hypersensitivity to Venlafaxine~* Myocardial infarction an/or unstable angina within 6 months of screening~* History of seizure disorder

- Gender: FEMALE
- Minimum Age: 45 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): desvenlafaxine succinate (DVS) SR
- 2 (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).